Cargando…
Immunogenic-cell-killing and immunosuppression-inhibiting nanomedicine
Combining chemo-therapeutics with immune checkpoint inhibitors facilitates killing cancer cells and activating the immune system through inhibiting immune escape. However, their treatment effects remain limited due to the compromised accumulation of both drugs and inhibitors in certain tumor tissues...
Autores principales: | Wang, Ying, Gao, Di, Liu, Yan, Guo, Xiaoqing, Chen, Shuojia, Zeng, Li, Ma, Jinxuan, Zhang, Xingcai, Tian, Zhongmin, Yang, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689277/ https://www.ncbi.nlm.nih.gov/pubmed/33294730 http://dx.doi.org/10.1016/j.bioactmat.2020.11.016 |
Ejemplares similares
-
Multifunctional Cargo-Free Nanomedicine for Cancer Therapy
por: Wang, Ying, et al.
Publicado: (2018) -
Research Progress of Conjugated Nanomedicine for Cancer Treatment
por: Zhao, Bin, et al.
Publicado: (2022) -
Targeting Hypoxic Tumors with Hybrid Nanobullets for Oxygen-Independent Synergistic Photothermal and Thermodynamic Therapy
por: Gao, Di, et al.
Publicado: (2021) -
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020) -
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
por: Zhu, Yuefei, et al.
Publicado: (2020)